Skip to content

Do We Really Bleed in Percutaneous Nephrolithotomy? A Single-Surgeon, Single-Center Experience

Do We Really Bleed in Percutaneous Nephrolithotomy? A Single-Surgeon, Single-Center Experience

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07360795
Enrollment
500
Registered
2026-01-22
Start date
2022-08-01
Completion date
2025-12-20
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Keywords

Perkütan Nefrolitotomi, Clavien-Dindo Sınıflandırması, Kan Transfüzyonu

Brief summary

Percutaneous nephrolithotomy (PCNL) is an effective and guideline-recommended surgical technique for the treatment of large and complex renal stones; however, perioperative bleeding remains one of its most significant complications. Reported bleeding and transfusion rates vary widely in the literature, potentially due to differences in surgical technique, surgeon experience, and institutional practices. This retrospective, single-center study aims to evaluate perioperative and postoperative bleeding outcomes, transfusion requirements, and bleeding-related complications in patients who underwent PCNL performed by a single surgeon. The findings are intended to clarify whether the real-world bleeding risk associated with PCNL is lower than commonly reported.

Detailed description

Percutaneous nephrolithotomy (PCNL) is an effective and guideline-recommended surgical technique for the treatment of large and complex renal stones; however, perioperative bleeding remains one of its most significant complications. Reported bleeding and transfusion rates vary widely in the literature, potentially due to differences in surgical technique, surgeon experience, and institutional practices. This retrospective, single-center study aims to evaluate perioperative and postoperative bleeding outcomes, transfusion requirements, and bleeding-related complications in patients who underwent PCNL performed by a single surgeon. The findings are intended to clarify whether the real-world bleeding risk associated with PCNL is lower than commonly reported. This is a retrospective, single-center observational study conducted at Elazığ Fethi Sekin City Hospital, Türkiye. Medical records of patients who underwent percutaneous nephrolithotomy between August 1, 2022, and December 20, 2025, will be reviewed retrospectively using the hospital information management system and anesthesia records. All PCNL procedures were performed by a single experienced urologist using standardized surgical techniques. Demographic characteristics, perioperative variables, laboratory values, bleeding parameters, transfusion requirements, postoperative outcomes, and complications will be analyzed. Surgical complications will be classified according to the Clavien-Dindo classification system.

Interventions

PROCEDUREPercutaneous Nephrolithotomy

Percutaneous nephrolithotomy performed according to standard clinical practice for the treatment of renal calculi. All procedures were completed by a single experienced surgeon. No additional intervention, modification, or experimental procedure was applied as part of the study. Data related to perioperative and postoperative bleeding outcomes were collected retrospectively from existing medical records.

Sponsors

Elazıg Fethi Sekin Sehir Hastanesi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who underwent percutaneous nephrolithotomy (PCNL) * Availability of complete intraoperative and postoperative follow-up data * Availability of preoperative and postoperative complete blood count and biochemical laboratory results

Exclusion criteria

* Pregnancy * Conversion to open or laparoscopic surgery during PCNL * Simultaneous additional surgical procedures, bilateral or synchronous bilateral PCNL * Known coagulation disorders, hematological diseases, or active bleeding in the preoperative period * Use of anticoagulant or antiplatelet therapy without appropriate perioperative management * Preoperative blood transfusion requirement * Severe intraoperative hemodynamic instability affecting the surgical course * Missing hemoglobin or hematocrit data, insufficient transfusion or complication records * Inadequate postoperative follow-up or transfer to another institutionConversion to open or laparoscopic surgery during PCNL * Simultaneous additional surgical procedures, bilateral or synchronous bilateral PCNL * Known coagulation disorders, hematological diseases, or active bleeding in the preoperative period * Use of anticoagulant or antiplatelet therapy without appropriate perioperative management * Preoperative blood transfusion requirement * Severe intraoperative hemodynamic instability affecting the surgical course * Missing hemoglobin or hematocrit data, insufficient transfusion or complication records * Inadequate postoperative follow-up or transfer to another institution

Design outcomes

Primary

MeasureTime frameDescription
Change in Hemoglobin LevelFrom the preoperative baseline to postoperative day 1 and throughout the length of hospital stay.The difference between preoperative and postoperative hemoglobin levels (g/dL) will be evaluated in patients undergoing percutaneous nephrolithotomy

Secondary

MeasureTime frameDescription
Change in Hematocrit LevelFrom the preoperative baseline to postoperative day 1 and throughout the length of hospital stay.The change in hematocrit (%) values between the preoperative and postoperative periods will be assessed
Estimated Intraoperative Blood LossDuring the surgical procedure.Estimated blood loss (mL) during percutaneous nephrolithotomy will be assessed based on intraoperative surgical records.
Postoperative Blood Transfusion RequirementFrom postoperative day 1 until hospital discharge.The need for postoperative blood transfusion (yes/no) and the number of transfused packed red blood cell units will be recorded.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026